This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

Gold, incentives and meh

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.


Pregabalin patent dispute could have cost the NHS up to £54m


1:37 - this is not 'The Government's money' - this is money allocated to the NHS which could be paying for something else. 1.58 - drug companies make huge profits - they have patents to protect their rights and once these are over, other companies can step in and make these drugs at nearer to cost price. If we simply pay top branded prices, there will be no money for anything else. It is up to us as GPs to make sure we do not waste resources so that our patients can benefit the most from the resources the NHS can offer. To waste money by not caring seems completely alien to me. I will prescribe drugs that are expensive if these will help my patients but will always try to choose the most cost effective treatments. Isn't that part of our job?

Posted date

22 Jan 2016

Posted time